Epidemiology and molecular analyses of respiratory syncytial virus in the 2021-2022 season in northern Italy.

RSV genotypes RSV subgroups epidemiology pediatric cohort phylogeny respiratory syncytial virus

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2023
Historique:
received: 24 10 2023
accepted: 28 11 2023
medline: 19 1 2024
pubmed: 19 1 2024
entrez: 19 1 2024
Statut: epublish

Résumé

Human respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infection among infants and young children worldwide, with seasonal peaks in January and February. This study aimed to characterize the RSV samples from a pediatric cohort in the 2021-2022 season in Italy. In total, 104 samples were collected from pediatric patients attending the "Vittore Buzzi" Children's Hospital in Milan, Italy in the 2021-2022 season. RT-PCR and next-generation sequencing were used to discriminate subgroups and obtain whole genomes. Maximum likelihood and Bayesian phylogenetic methods were used to analyze Italian sequences in the European contest and date Italian clusters. The median age was 78 days, and 76.9% of subjects required hospitalization, with a higher proportion of patients under 3 months of age. An equal proportion of subgroups A (GA2.3.5) and B (GB5.0.5a) was found, with significant differences in length of hospitalization, days of supplemental oxygen treatment, and intravenous hydration duration. Phylogeny highlighted 26 and 37 clusters containing quite the total of Italian sequences for RSV-A and -B, respectively. Clusters presented a tMRCA between December 2011-February 2017 and May 2014-December 2016 for A and B subgroups, respectively. Compared to European sequences, specific mutations were observed in Italian strains. These data confirmed a more severe clinical course of RSV-A, particularly in young children. This study permitted the characterization of recent Italian RSV whole genomes, highlighting the peculiar pattern of mutations that needs to be investigated further and monitored.

Sections du résumé

Background UNASSIGNED
Human respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infection among infants and young children worldwide, with seasonal peaks in January and February. This study aimed to characterize the RSV samples from a pediatric cohort in the 2021-2022 season in Italy.
Methods UNASSIGNED
In total, 104 samples were collected from pediatric patients attending the "Vittore Buzzi" Children's Hospital in Milan, Italy in the 2021-2022 season. RT-PCR and next-generation sequencing were used to discriminate subgroups and obtain whole genomes. Maximum likelihood and Bayesian phylogenetic methods were used to analyze Italian sequences in the European contest and date Italian clusters.
Results UNASSIGNED
The median age was 78 days, and 76.9% of subjects required hospitalization, with a higher proportion of patients under 3 months of age. An equal proportion of subgroups A (GA2.3.5) and B (GB5.0.5a) was found, with significant differences in length of hospitalization, days of supplemental oxygen treatment, and intravenous hydration duration. Phylogeny highlighted 26 and 37 clusters containing quite the total of Italian sequences for RSV-A and -B, respectively. Clusters presented a tMRCA between December 2011-February 2017 and May 2014-December 2016 for A and B subgroups, respectively. Compared to European sequences, specific mutations were observed in Italian strains.
Conclusion UNASSIGNED
These data confirmed a more severe clinical course of RSV-A, particularly in young children. This study permitted the characterization of recent Italian RSV whole genomes, highlighting the peculiar pattern of mutations that needs to be investigated further and monitored.

Identifiants

pubmed: 38239726
doi: 10.3389/fmicb.2023.1327239
pmc: PMC10794773
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1327239

Informations de copyright

Copyright © 2024 Lai, Bergna, Fabiano, della Ventura, Fumagalli, Mari, Loiodice, Zuccotti and Zehender.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Alessia Lai (A)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Annalisa Bergna (A)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Valentina Fabiano (V)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Pediatric Department, "Vittore Buzzi" Children's Hospital, Milan, Italy.

Carla Della Ventura (CD)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Giulia Fumagalli (G)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Alessandra Mari (A)

Pediatric Department, "Vittore Buzzi" Children's Hospital, Milan, Italy.

Martina Loiodice (M)

Pediatric Department, "Vittore Buzzi" Children's Hospital, Milan, Italy.

Gian Vincenzo Zuccotti (GV)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.
Pediatric Department, "Vittore Buzzi" Children's Hospital, Milan, Italy.

Gianguglielmo Zehender (G)

Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy.

Classifications MeSH